This 90 minute presentation that will be accredited with SA-CME by the ABR will review the state-of-the-art treatment approaches for lung cancer.

PRO Journal SA-CME activity for July-August, 2018 (Volume 8, Issue 2) summarizes recent evidence-based guidelines on palliation of stage III and IV non-small cell lung cancer.

This session will review the current standard treatment paradigm for all stages of lung cancer, with a special focus on radiation therapy, including the latest recommendations on stereotactic radiation therapy.  The session will also review the evolving treatment of metastatic lung cancer, especi

This session will review the current standard treatment paradigm for all stages of lung cancer, with a special focus on radiation therapy, including the latest recommendations on stereotactic radiation therapy.  The session will also review the evolving treatment of metastatic lung cancer, especi

This session will discuss current evidence and emerging treatment options in the management of SCLC. An overview of SCLC will be provided including definitions, staging, epidemiology, pathology and other general considerations.

March 16-18, 2017

IJROBP Journal SA-CME activity from November 1, 2015 (Vol. 93, Iss. 3, pg. 597-605) looks at chemoradiotherapy for non-small cell lung cancer. This course is available from September 13, 2015, through 11:59 p.m. Eastern time on September 12, 2017.

IJROBP Journal SA-CME activity from November 15, 2015 (Vol. 93, Iss. 4, pg.

Radiation Oncologists today are inundated with marketing messages claiming the high accuracy of one respiratory management technique compared to others in the market.

IJROBP Journal SA-CME activity from July 15, 2016 (Volume 95, Issue 4) looks at technology and technique related to the use of 4-D CT data to calculate lung function maps to potentially identify avoidance regions during radiation planning for lung cancer treatment.